SCHEMBL2875007

SCHEMBL2875007

CCCCc1ccc(C#Cc2ccc(CN(Cc3ccc(C(=O)OC)cc3)C(=O)CCC3CCCC3)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 2/20 0.43
CNR2 P34972 1/20 0.43
CYP4A11 Q02928 2/20 0.41
HTR5A P47898 4/20 0.41
HTR1A P08908 1/20 0.41
DRD2 P14416 1/20 0.41
DRD4 P21917 1/20 0.41
HTR1D P28221 1/20 0.41
HTR1B P28222 1/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
HTR7 P34969 1/20 0.41
ADRA1B P35368 1/20 0.41
DRD3 P35462 1/20 0.41
HTR2B P41595 1/20 0.41
HTR6 P50406 1/20 0.41
CYP4F2 P78329 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13711651 0.91 SLC6A4 (0.52) SLC6A4CNR2CYP4A11HTR5AHTR1A
SCHEMBL1734729 0.89 RARB (0.46) SLC6A4CNR2HTR5AHTR1ADRD2
SCHEMBL2861907 0.86 PDE6D (0.48) CYP4A11CYP4F2HDAC3HDAC1HDAC2
SCHEMBL2860171 0.83 NR1H4 (0.40) SLC6A4CNR2DRD2DRD3THRA
SCHEMBL13513527 0.83 ACACB (0.38) CNR2CYP4A11CYP4F2LPAR1LPAR5
SCHEMBL2858230 0.82 TAOK1 (0.38) SLC6A4CNR2CYP4A11CYP4F2
SCHEMBL2857437 0.81 FFAR1 (0.51) SLC6A4CNR2HTR5AHTR1ADRD2
SCHEMBL1736062 0.80 PTPN11 (0.55) SLC6A4CNR2HTR5AHTR1ADRD2
SCHEMBL2851668 0.80 LTB4R2 (0.51) SLC6A4CNR2AGTR1
SCHEMBL2853693 0.80 PTPN11 (0.41) SLC6A4CNR2HTR5AHTR1ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1654247-B1 ALKYNYL ARYL CARBOXAMIDES MERCK SERONO SA (CH) 2010-01-20 EP disclosed
US-7589232-B2 Alkynyl aryl carboxamides LABORATORIES SERONO S.A. (CH) 2009-09-15 US disclosed
US-7589232-B2 Alkynyl aryl carboxamides LABORATORIES SERONO S.A. (CH) 2009-09-15 US disclosed
US-20070105913-A1 Alkynyl aryl carboxamides APPLIED RESEARCH SYSTEMS ARS HOLDINGS N.V. (NL) 2007-05-10 US disclosed
US-20070105913-A1 Alkynyl aryl carboxamides APPLIED RESEARCH SYSTEMS ARS HOLDINGS N.V. (NL) 2007-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105913-A1 Alkynyl aryl carboxamides ECHS1, IRS1, HCCS SLC6A4 3541/4885CNR2 198/4885CYP4A11 294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.